These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
173 related items for PubMed ID: 28239520
1. Association of vitamin D status and clinical and radiological outcomes in a treated MS population in Poland. Wawrzyniak S, Mikołajewska E, Kuczko-Piekarska E, Niezgodzińska-Maciejek A, Goch A. Brain Behav; 2017 Feb; 7(2):e00609. PubMed ID: 28239520 [Abstract] [Full Text] [Related]
2. Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis. Brola W, Sobolewski P, Szczuchniak W, Góral A, Fudala M, Przybylski W, Opara J. Eur J Clin Nutr; 2016 Sep; 70(9):995-9. PubMed ID: 27026420 [Abstract] [Full Text] [Related]
3. Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis. Thouvenot E, Orsini M, Daures JP, Camu W. Eur J Neurol; 2015 Mar; 22(3):564-9. PubMed ID: 25530281 [Abstract] [Full Text] [Related]
4. Vitamin D and disability in relapsing-remitting multiple sclerosis in patients with a Mexican background. Rito Y, Flores J, Fernández-Aguilar A, Escalante-Membrillo C, Barboza MA, Amezcua L, Corona T. Acta Neurol Belg; 2018 Mar; 118(1):47-52. PubMed ID: 28975580 [Abstract] [Full Text] [Related]
5. 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis. Soilu-Hänninen M, Airas L, Mononen I, Heikkilä A, Viljanen M, Hänninen A. Mult Scler; 2005 Jun; 11(3):266-71. PubMed ID: 15957505 [Abstract] [Full Text] [Related]
6. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis. Soilu-Hänninen M, Laaksonen M, Laitinen I, Erälinna JP, Lilius EM, Mononen I. J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):152-7. PubMed ID: 17578859 [Abstract] [Full Text] [Related]
7. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Smolders J, Menheere P, Kessels A, Damoiseaux J, Hupperts R. Mult Scler; 2008 Nov; 14(9):1220-4. PubMed ID: 18653736 [Abstract] [Full Text] [Related]
8. Vitamin D supplementation reduces relapse rate in relapsing-remitting multiple sclerosis patients treated with natalizumab. Laursen JH, Søndergaard HB, Sørensen PS, Sellebjerg F, Oturai AB. Mult Scler Relat Disord; 2016 Nov; 10():169-173. PubMed ID: 27919484 [Abstract] [Full Text] [Related]
15. Lower 25-Hydroxyvitamin D Is Associated with Higher Relapse Risk in Patients with Relapsing-Remitting Multiple Sclerosis. Wang C, Zeng Z, Wang B, Guo S. J Nutr Health Aging; 2018 Apr 17; 22(1):38-43. PubMed ID: 29300420 [Abstract] [Full Text] [Related]
16. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. Smolders J, Thewissen M, Peelen E, Menheere P, Tervaert JW, Damoiseaux J, Hupperts R. PLoS One; 2009 Aug 13; 4(8):e6635. PubMed ID: 19675671 [Abstract] [Full Text] [Related]
18. Bone metabolism and vitamin D status in patients with multiple sclerosis. Kępczyńska K, Zajda M, Lewandowski Z, Przedlacki J, Zakrzewska-Pniewska B. Neurol Neurochir Pol; 2016 Aug 13; 50(4):251-7. PubMed ID: 27375138 [Abstract] [Full Text] [Related]